Biz Brief: Micromet Stock Rises on Cancer Drug Trial Results

Micromet shares traded some 3.3% higher on Monday after the small-cap biotech announced that its candidate drug blinatumomab led to remission in almost four-fifths of leukemia patients in a Phase II trial. It also said that a Phase I trial showed the drug induced durable remission in patients with non-Hodgkin lymphoma.

Daily Blogwatch: Stocks Most Likely to Snap Back

Some of the best reads for investors from around the Web, including bullishness from Goldman Sachs and forecasters, intriguing small-cap stocks and a video of Treasury Secretary Tim Geithner playing basketball.

Cancer: More Environmental Risks and Even Higher Costs

"The American people -- even before they are born -- are bombarded continually with myriad combinations of these dangerous exposures," the President's Cancer Panel says. And that means more spending on prevention in addition to treatment.

KFC Is Taking Unfair Heat for Its Breast Cancer Campaign

Fast-food chain KFC's Buckets for the Cure campaign to raise money for breast cancer has already generated more then $2.3 million. But it has also generated angry responses from media outlets and cancer advocates who charge the company with animal cruelty, encouraging obesity, and "pinkwashing."

Roche Sales Grow on Cancer Drug Demand

Roche shares climbed nearly 2% Thursday after the Swiss drugmaker posted first-quarter sales that rose 6% to 12.2 billion Swiss francs ($11.61 billion), thanks to strong demand for key cancer drugs. The results beat the average sales forecast.

Aspirin May Boost Breast Cancer Survival

A study of 4,164 women who had been diagnosed with breast cancer showed that women taking aspirin regularly are 50% less likely to die and had a 50% lower risk of the cancer returning. But the findings still need to be confirmed through clinical trials.

Voters Support a $1 Increase in Cigarette Tax

A new nationwide poll finds that two-thirds of U.S. voters support a $1 increase in tobacco taxes per pack. The tax could raise more than $9.1 billion in new annual revenue for states, says the report released by a coalition of public health organizations claims.

Preview: Look for Eli Lilly to Report a Solid Quarter

Pharmaceutical giant Eli Lilly -- maker of Prozac and Cialis -- is expected to post solid fourth-quarter profits on Thursday after a recent restructuring. But the results will likely be lower than the year-ago quarter.

Good Results for Celgene's Cancer Drug

Drug maker Celgene (CELG) says its multiple myeloma cancer pill reduced the risk of progression by half among newly diagnosed patients who used the drug and chemotherapy compared with those who only used chemotherapy.